Abstract:Objective: Isolated dissection of the mesenteric vessels is rare but increasingly recognized. This study aimed to evaluate patient characteristics, primary treatment, and subsequent outcomes of mesenteric dissection using multi-institutional data. Methods: All patients at participant hospitals between January 2003 and December 2015 with dissection of the celiac artery (or its branches) or dissection of the superior mesenteric artery (SMA) were included. Patients with an aortic dissection were excluded. Demographic, treatment, and follow-up data were collected. The primary outcomes included late vessel thrombosis (LVT) and aneurysmal degeneration (AD). Results: Twelve institutions identified 227 patients (220 with complete treatment records) with a mean age of 55 ± 12.5 years. Median time to last follow up was 15 months (interquartile range, 3.8-32). Most patients were men (82% vs 18% women) and symptomatic at presentation (162 vs 65 asymptomatic). Isolated SMA dissection was more common than celiac artery dissection (n = 158 and 81, respectively). Concomitant dissection of both arteries was rare (n = 12). The mean dissection length was significantly longer in symptomatic patients than in asymptomatic patients in both the celiac artery (27 vs 18 mm; P = .01) and the SMA (64 vs 40 mm; P < .001). Primary treatment was medical in 146 patients with oral anticoagulation or antiplatelet therapy (n = 76 and 70, respectively), whereas 56 patients were observed. LVT occurred in six patients, and 16 patients developed AD (3% and 8%, respectively). For symptomatic patients without evidence of ischemia (n = 134), there was no difference in occurrence of LVT with medical therapy compared with observation alone (9% vs 0%; P = .35). No asymptomatic patient (n = 64) had an episode of LVT at 5 years. AD rates did not differ among symptomatic patients without ischemia treated with medical therapy or observed (9% vs 5%; P = .95). Surgical or endovascular intervention was performed in 18 patients (3 ischemia, 13 pain, 1 AD, 1 asymptomatic). Excluding the patients treated for ischemia, there was no difference in LVT with surgical intervention vs medical management (one vs five; P = .57). Conclusions: Asymptomatic patients with isolated mesenteric artery dissection may be observed and followed up with intermittent imaging. Symptomatic patients tend to have longer dissections than asymptomatic patients. Symptomatic isolated mesenteric artery dissection without evidence of ischemia does not require anticoagulation and may be treated with antiplatelet therapy or observation alone.

Primary Conservative Therapy for Symptomatic Isolated Mesenteric Artery Dissection with Severely Compressed True Lumen or Large Dissecting Aneurysm.

Mid-term Results of the Treatment of Isolated Dissection of the Celiac Artery: A Comparative Analysis of Endovascular Versus Conservative Therapy.

Primary Conservative Treatment for Peritonitis-Absent Symptomatic Isolated Dissection of the Superior Mesenteric Artery with Severely Compressed True Lumen

Management Strategy Based on Disease Stages for Patients with Symptomatic Isolated Mesenteric Artery Dissection.

Endovascular Treatment of Spontaneous Isolated Dissection of the Superior Mesenteric Artery

Endovascular treatment of isolated abdominal aortic dissection and postoperative aortic remodeling.

Mesenteric Artery Remodeling after Conservative Management in Patients with Isolated Mesenteric Artery Dissection

Morphologic Findings and Management Strategy of Spontaneous Isolated Dissection of the Celiac Artery.

Vasodilator and endovascular therapy for isolated superior mesenteric artery dissection.

Midterm Results of the Conservative, Bare Stent, and Bare Stent-Assisted Coiling Treatments for Symptomatic Isolated Superior Mesenteric Artery Dissection

Therapeutic Regimen Options for Isolated Superior Mesenteric Artery Dissection

Immediate and Middle Term Outcome of Symptomatic Spontaneous Isolated Dissection of the Superior Mesenteric Artery

Effectiveness of the Conservative Therapy for Symptomatic Isolated Celiac Artery Dissection

Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery

Percutaneous endovascular reconstruction with bare stent implantation for isolated superior mesenteric artery dissection.

Clinical Features and Therapeutic Options for Isolated Visceral Artery Dissection.

Risk factor analysis and treatment outcome of patients with spontaneous isolated celiac axis or superior mesenteric artery dissection

Medical therapy and intervention do not improve uncomplicated isolated mesenteric artery dissection outcomes over observation alone

Conservative versus stent treatment for spontaneous isolated superior mesenteric artery dissection after the failure of initial 3 days' conservative treatment: A 10-year follow-up study

Value of endovascular stent placement for symptomatic spontaneous isolated superior mesenteric artery dissection.

Endovascular Treatment of Isolated Dissection of the Superior Mesenteric Artery